A detailed history of Center For Financial Planning, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 17,013 shares of ABT stock, worth $2.18 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
17,013
Previous 17,013 -0.0%
Holding current value
$2.18 Million
Previous $1.94 Million 0.77%
% of portfolio
0.26%
Previous 0.26%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$100.07 - $118.13 $83,158 - $98,166
-831 Reduced 4.66%
17,013 $1.94 Million
Q3 2023

Oct 24, 2023

BUY
$95.53 - $114.62 $6,591 - $7,908
69 Added 0.39%
17,844 $1.73 Million
Q2 2023

Aug 09, 2023

BUY
$100.78 - $112.29 $13,806 - $15,383
137 Added 0.78%
17,775 $1.94 Million
Q1 2023

May 02, 2023

SELL
$96.86 - $114.01 $6,392 - $7,524
-66 Reduced 0.37%
17,638 $1.79 Million
Q4 2022

Jan 27, 2023

SELL
$95.06 - $111.52 $7,129 - $8,364
-75 Reduced 0.42%
17,704 $0
Q3 2022

Oct 14, 2022

BUY
$96.76 - $112.03 $222,935 - $258,117
2,304 Added 14.89%
17,779 $1.72 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $4,593 - $5,551
45 Added 0.29%
15,475 $1.68 Million
Q3 2021

Oct 27, 2021

BUY
$116.66 - $129.06 $54,946 - $60,787
471 Added 3.15%
15,430 $1.82 Million
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $109,166 - $128,614
1,003 Added 7.19%
14,959 $1.79 Million
Q2 2020

Aug 06, 2020

SELL
$76.57 - $98.0 $2,373 - $3,038
-31 Reduced 0.22%
13,956 $1.28 Million
Q1 2020

May 11, 2020

BUY
$62.82 - $91.86 $20,039 - $29,303
319 Added 2.33%
13,987 $1.1 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $1.07 Million - $1.19 Million
13,668 New
13,668 $1.19 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Center For Financial Planning, Inc. Portfolio

Follow Center For Financial Planning, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.